| Literature DB >> 32121158 |
Ramona Figat1, Anita Śliwińska2, Anna Stochmal3, Agata Soluch3, Magdalena Sobczak1, Anna Zgadzaj1, Katarzyna Sykłowska-Baranek2, Agnieszka Pietrosiuk2.
Abstract
Traditional medicinal plants are an important source of active compounds with potential antimutagenic activity. Polyscias filicifolia Bailey (Araliaceae) is a South Asian traditional herb used as an adaptogenic and cardiac drug. Extracts of P. filicifolia contain a wide range of biologically active compounds like phenolic acids and triterpenoid saponins. In the present study. antigenotoxic potential of three naturally occurring phenolic acids and extracts of P. filicifolia growing in vitro with the addition of elicitors was evaluated against direct (4-nitroquinoline-N-oxide (4NQO) and mitomycin C (MMC)) and indirect mutagens (2-aminoanthracene (2AA)). The evaluation was made using a bacterial umu-test. Moreover, the ability to prevent photogenotoxicity induced by chlorpromazine (CPZ) under UVA irradiation was measured. The phytochemical profiling of examined extracts revealed the presence of numerous compounds with the prevelance of chlorogenic, caffeic, and ferulic acid derivatives; however, saponin fractions were also determined. The antioxidant potential of extracts strictly correlated with their composition. The tested extracts exhibited high antigenotoxic activity if the assay was performed with 2AA and metabolic activation. Moreover, the extracts slightly decreased the MMC-induced genotoxicity. However, an increase of the genotoxic effect was observed in the assay performed with 4NQO. In addition, photo-antigenotoxic activity was observed. In our study, phenolic acids exhibited lower activity than the extracts.Entities:
Keywords: Salmonella typhimurium; antigenotoxic agents; caffeic acid; chlorogenic acid; ferulic acid
Mesh:
Substances:
Year: 2020 PMID: 32121158 PMCID: PMC7179227 DOI: 10.3390/molecules25051090
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The content (mg/g DW) of phenolic acids: chlorogenic (CGA), caffeic (CA), ferulic acid (FA), total phenolics (GAE mg/g DW), and total flavonoids (QE mg/g DW) in elicited shoots of P. filcifolia cultivated in vitro.
| Extract Type | CGA mg/g | CA mg/g | FA mg/g | Total Content Phenolics | Total Content Flavonoids |
|---|---|---|---|---|---|
| EXT0 | 1.18 ± 0.07 * | 0.6 ± 0.13 | 0.02± 0.001 | 1.5 ± 0.35 * | 1.0 ± 0.17 * |
| EXT(SA) | 2.8 ± 0.13 | 0.8 ± 0.22 | 0.07 ± 0.08 | 3.9 ± 0.53 * | 2.5 ± 0.35 * |
| EXT(MeJA) | 3.1 ± 0.24 | 0. 8 ± 0.29 | 0.09 ± 0.01 | 5.3 ± 0.49 * | 3.4 ± 0.35 * |
| EXT(MeJA+SA) | 4.2± 0.17 * | 0.9 ± 0.23 | 0.1 ± 0.23 | 7.8 ± 0.21 * | 4.3 ± 0.27 * |
EXT0—extract of control shoots cultivated on LS medium without elicitors; EXT(SA)—extracts of shoots elicited with salicylic acid (50 M); EXT(MeJA)—extracts of shoots elicited with methyl jasmonate (200 M); EXT(MeJA + SA)—extracts of shoots elicited with salicylic acid and methyl jasmonate (200 and 50 M, respectively). Data are expressed as means ± SD from two independent experiments performed in triplicate. Asterisk (*) indicate significant differences at p < 0.05 among various extract types.
Figure 1Antioxidant properties assessed using ABTS and DPPH methods for extracts obtained from shoots of P. filicifolia cultivated under various elicitor treatments: salicylic acid (SA, 50 M), methyl jasmonate (MeJA, 200 M), and (MeJA 200 M + SA 50 M): Data are expressed as means ± SD from two independent experiments performed in triplicate. All differences among various extract types in antioxidant activity are statistically significant at p< 0.05.
Figure 2The percentage share of groups of chemical constituents in tested methanolic extracts of P. filicifolia determined on the basis of the UHPLC-DAD-MS/MS analysis.
Figure 3Results of two different cytotoxicity assays: (a) Neutral Red Uptake (NRU) (b) MTT.
Evaluation of genotoxic activity of the tested extracts based on IR values.
| IR (mean ± SD) | Tested Material Concentration [mg/mL] | ||||
|---|---|---|---|---|---|
|
|
|
|
| 2 | |
| EXT0 (−S9) | 1.0 ± 0.25 | 1.1 ± 0.43 | 1.0 ± 0.16 | 0.97 ± 0.08 | |
Each value is expressed as mean ± standard deviation from at least 3 independent biological evaluation.
Evaluation of genotoxic activity of the phenolic acids based on IR values of the highest tested concentration (10 g/mL).
| IR (mean±SD) | |
|---|---|
| CGA (−S9) | 1.3 ± 0.19 |
Each value is expressed as mean ± standard deviation from at least 3 independent biological evaluations.
Evaluation of antigenotoxic activity based on IR values for the control—genotoxins 4-nitroquinoline-N-oxide (4NQO) and mitomycin C (MMC)—and the mixture of genotoxins with the tested compounds.
| Concentration of | 4NQO 0.25 [ | 4NQO 0.05 [ | MMC 0.02 [ | MMC 0.004 [ | ||||
|---|---|---|---|---|---|---|---|---|
| IR (mean | Antigenotox. | IR (mean | Antigenotox. | IR (mean | Antigenotox. | IR (mean | Antigenotox. | |
| 0 (control) | 9 ± 2.6 | - | 3.7 ± 0.99 | - | 5.3 ± 0.70 | - | 2.4 ± 0.42 | - |
IR values of the control are expressed as mean ± standard deviation of all experiments. Asterisk (*) indicate significant differences at p < 0.05. A significant difference is calculated between IR values of the control measured in the same experiment as tested mixtures. Each value is expressed as mean ± standard deviation from at least 3 independent biological evaluations.
Evaluation of antigenotoxic activity based on IR values for the control—genotoxins 2-aminoanthracene (2AA)—and the mixture of genotoxins with the tested extracts.
| Tested Extracts | 2AA 10 ( | 2AA 1 ( | ||
|---|---|---|---|---|
| IR (mean | Antigenotox. | IR (mean | Antigenotox. | |
| 0 (control) | 6 ± 1.5 | - | 4.5 ± 0.99 | - |
Evaluation of antigenotoxic activity based on IR values for the control—genotoxins 2AA—and the mixture of genotoxins with PhAs.
| Tested Extracts | 2AA 10 ( | 2AA 1 ( | ||
|---|---|---|---|---|
| IR (mean ± SD) | Antigenotox. | IR (mean ± SD) | Antigenotox. | |
| 0 (control) | 4 ± 1.3 | - | 3.37 ± 0.72 | - |
Each value is expressed as mean ± standard deviation from at least 3 independent biological evaluations. Asterisk (*) indicate significant differences at p < 0.05.
Evaluation of anti-photogenotoxic activity based on IR values for the control—photogenotoxin chlorpromazine (CPZ)—and the mixture of CPZ with EXT(MeJA + SA) and PhAs.
| Tested Concentration | CPZ 10 ( | CPZ 5 ( | ||
|---|---|---|---|---|
| IR (mean | Anti-Photogenotox. | IR (mean | Anti-Photogenotox. | |
| 0 (control) | 5.1 ± 0.78 | - | 3.6 ± 0.40 | - |
Each value is expressed as mean ± standard deviation from at least 3 independent biological evaluations. Asterisk (*) indicate significant differences at p < 0.05.